Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

被引：0
|
作者：
Wen-Fei Li
Ying-Qin Li
Lei Chen
Yuan Zhang
Rui Guo
Fan Zhang
Hao Peng
Ying Sun
Jun Ma
机构：
[1] Sun Yat-sen University Cancer Center,Department of Radiation Oncology
[2] State Key Laboratory of Oncology in South China,undefined
[3] Collaborative Innovation Center for Cancer Medicine,undefined
来源：
BMC Cancer | / 15卷
关键词：
Nasopharyngeal carcinoma; Concurrent chemoradiotherapy; Induction chemotherapy; Intensity-modulated radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma
    Wang Fangzheng
    Sun Quanquan
    Jiang Chuner
    Wang Lei
    Yan Fengqin
    Ye Zhimin
    Liu Tongxin
    Xu Min
    Wu Peng
    Jiang Haitao
    Aizawa, Rihito
    Sakamoto, Masoto
    Wang Yuezhen
    Fu Zhenfu
    ONCOTARGET, 2017, 8 (57) : 96798 - 96808
  • [22] Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis
    Chen, Jiawei
    Ding, Jianming
    Xu, Yiying
    Hong, Huiling
    Lin, Xiaoting
    Xu, Mengting
    Yan, Linghui
    Xu, Ting
    Fei, Zhaodong
    Chen, Chuanben
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (08)
  • [23] Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study
    Zhang, Lu-Ning
    Gao, Yuan-Hong
    Lan, Xiao-Wen
    Tang, Jie
    OuYang, Pu-Yun
    Xie, Fang-Yun
    ORAL ONCOLOGY, 2015, 51 (10) : 950 - 956
  • [24] Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
    Zeng, Lei
    Guo, Pi
    Li, Jin-Gao
    Han, Fei
    Li, Qiang
    Lu, Yong
    Deng, Xiao-Wu
    Zhang, Qing-Ying
    Lu, Tai-Xiang
    ONCOTARGET, 2015, 6 (36) : 39373 - 39383
  • [25] Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis
    Chen, Yu-Pei
    Mao, Yan-Ping
    Zhang, Wen-Na
    Chen, Lei
    Tang, Ling-Long
    Li, Wen-Fei
    Liu, Xu
    Zhou, Guan-Qun
    Guo, Rui
    Sun, Ying
    Kang, Tie-Bang
    Zeng, Mu-Sheng
    Ma, Jun
    ONCOTARGET, 2016, 7 (12) : 14973 - 14982
  • [26] Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
    Yeh, Shyh-An
    Hwang, Tzer-Zen
    Wang, Chih-Chun
    Yang, Chuen-Chien
    Lien, Ching-Feng
    Wang, Chien-Chung
    Hsu, Tun-Yen
    Hsu, Ruey-Feng
    Shih, Yu-Chen
    Huang, Yaw-Chang
    Hsieh, Meng-Che
    Gau, Jhy-Shyan
    Chang, Liyun
    Lee, Tsair-Fwu
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (03) : 438 - 447
  • [27] The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma
    Zhang, Lei
    Shan, Guo-ping
    Li, Pu
    Cheng, Ping-jing
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [28] Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    He Xiayun
    Dan Ou
    Hongmei Ying
    Guopei Zhu
    Chaosu Hu
    Taifu Liu
    European Archives of Oto-Rhino-Laryngology, 2012, 269 : 1027 - 1033
  • [29] Treatment outcomes of induction chemotherapy combined with intensity-modulated radiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in Southeast China
    Wang, Peirong
    Dong, Feng
    Cai, Chuanshu
    Ke, Chunlin
    MEDICINE, 2021, 100 (33)
  • [30] A Multicentre UK Study of Outcomes of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy ± Chemotherapy
    Slevin, F.
    Pan, S.
    Mistry, H.
    Sen, M.
    Foran, B.
    Slevin, N.
    Dixon, L.
    Thomson, D.
    Prestwich, R.
    CLINICAL ONCOLOGY, 2020, 32 (04) : 238 - 249
12345